Episodes

  • S7:E3 – Morning Commute Podcast: Worth the Risk? Using Anti-Amyloid Therapies for Alzheimer’s Disease

    S7:E3 – Morning Commute Podcast: Worth the Risk? Using Anti-Amyloid Therapies for Alzheimer’s Disease
    Dec 15 2023

    In this episode our faculty take a look at the treatment-related side effects associated with some of the newer treatments for Alzheimer’s disease, with a focus on amyloid-related imaging abnormalities (ARIA). How do you weigh the risk and benefits for your patients?

    Visit www.morningcommutepodcast.com/alzheimers3 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
    Show more Show less
    28 mins
  • S7:E2 – Morning Commute Podcast: Untying the Beta-Amyloid Knots in Alzheimer’s Disease

    S7:E2 – Morning Commute Podcast: Untying the Beta-Amyloid Knots in Alzheimer’s Disease
    Dec 15 2023

    In this podcast, our faculty discuss talk some of the newer treatments for Alzheimer's disease, especially anti-beta-amyloid antibody treatments.

    Visit www.morningcommutepodcast.com/alzheimers2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
    Show more Show less
    27 mins
  • S7:E1 – Morning Commute Podcast: Drawing a Blank: When Does a Patient’s Forgetfulness Signal a Concern it Might Be Alzheimer’s Disease?

    S7:E1 – Morning Commute Podcast: Drawing a Blank: When Does a Patient’s Forgetfulness Signal a Concern it Might Be Alzheimer’s Disease?
    Dec 15 2023

    When is a patients cognitive difficulties a signal that they may be on the road to Alzheimer's disease? Our faculty discuss some of the recent advances making this diagnosis.

    Visit www.morningcommutepodcast.com/alzheimers1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
    Show more Show less
    27 mins
  • S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade

    S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade
    Apr 11 2022

    In this episode, our faculty looks at the latest treatments for multiple sclerosis—the newest sphingosine-1-phosphate receptor modulators. What is their mechanism of action? Which patients would benefit from them, and how are side effects and toxicities managed with these latest treatment options?

    Visit www.morningcommutepodcast.com/ms8 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
    Show more Show less
    23 mins
  • S2:E7 – Neurology Morning Commute: Getting UP to Speed on Multiple Sclerosis Management

    S2:E7 – Neurology Morning Commute: Getting UP to Speed on Multiple Sclerosis Management
    Apr 11 2022

    With the many treatments now available for the treatment of multiple sclerosis (MS), our faculty reviews this impressive therapeutic landscape and discusses how to choose the best ones for the individual MS patient.

    Visit www.morningcommutepodcast.com/ms7 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
    Show more Show less
    Less than 1 minute
  • S6:E2 – Neurology Morning Commute: Covid-19 Vaccines and Disease-Modifying Treatments for MS

    S6:E2 – Neurology Morning Commute: Covid-19 Vaccines and Disease-Modifying Treatments for MS
    Mar 18 2022
    Are there issues with getting the Covid-19 vaccine and boosters for patients with MS who are on disease-modifying therapies? In this podcast our faculty discuss the safety and efficacy of the vaccines, timing with disease-modifying therapies, and monoclonal antibodies for prevention and treatment.
    Show more Show less
    Less than 1 minute
  • S6:E1 – Neurology Morning Commute: Covid-19 Vaccines and the Patient with Multiple Sclerosis

    S6:E1 – Neurology Morning Commute: Covid-19 Vaccines and the Patient with Multiple Sclerosis
    Nov 30 2021
    What is the efficacy of Covid-19 vaccines for multiple sclerosis patients? In this podcast our faculty discuss vaccine safety, how vaccines are affected by disease modifying drugs, and the importance of the vaccines and boosters for this patient population.
    Show more Show less
    27 mins
  • S5:E1 – Neurology Morning Commute: New and Emerging Treatments for ALS

    S5:E1 – Neurology Morning Commute: New and Emerging Treatments for ALS
    Jul 15 2021

    In this podcast our faculty discuss new and emerging treatments for ALS, as well as managing some of the more debilitating symptoms of the disease.

    Visit www.morningcommutepodcast.com/als1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
    Show more Show less
    32 mins